C4 Therapeutics, Inc. (CCCC)
2.82
+0.12
(+4.44%)
USD |
NASDAQ |
Apr 02, 16:00
2.805
-0.02
(-0.53%)
After-Hours: 20:00
C4 Therapeutics Shareholders Equity (Quarterly) : 256.59M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Pfizer Inc. | 86.48B |
| Align Technology, Inc. | 4.049B |
| Biogen, Inc. | 18.26B |
| BrightSpring Health Services, Inc. | 1.875B |
| ACADIA Pharmaceuticals, Inc. | 1.227B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 371.94M |
| Total Liabilities (Quarterly) | 115.35M |
| Debt to Equity Ratio | 0.2338 |
| Current Ratio | 7.814 |
| Net Debt Paydown Yield | 0.77% |